Late-Breaking Science-1
Late-Breaking Science-1
11/22 10:00-12:00
103A (103A)
-
10:00- 12:00主持Harlan KRUMHOLZ (Yale School of Medicine, New Haven, USA), Filippo CREA (Catholic University of the Sacred Heart, Rome, Italy), David MOLITERNO (University of Kentucky Medical Center, USA), 王建安(WANG Jian-An) (浙江大学医学院附属第二医院), Yuan LU (Yale School of Medicine, USA), 赵冬(ZHAO Dong) (首都医科大学附属北京安贞医院), 李希(LI Xi) (河南阜外华中心血管病医院)
-
10:00-10:20The Burden of Cardiovascular Disease in China: Incidence Estimates from National Surveillance (2023)The Burden of Cardiovascular Disease in China: Incidence Estimates from National Surveillance (2023)
-
10:20-10:40Drug-Coated Balloon-Based Versus Drug-Eluting Stent-Only Treatment for Single de Novo Diffuse Coronary LesionsDrug-Coated Balloon-Based Versus Drug-Eluting Stent-Only Treatment for Single de Novo Diffuse Coronary Lesions
-
10:40-11:00Non-invasive Focused Power Ultrasound Therapy Targeting Inferior Perirenal Adipose Tissue for Drug Naive Hypertension: A Randomized, Sham-controlled, Proof-of-concept Trial (PARADISE-HTN-II)Non-invasive Focused Power Ultrasound Therapy Targeting Inferior Perirenal Adipose Tissue for Drug Naive Hypertension: A Randomized, Sham-controlled, Proof-of-concept Trial (PARADISE-HTN-II)
-
11:40-12:00Long-Term Efficacy and Safety of SHR-1918 in Patients With Suboptimally Controlled HyperlipidemiaLong-Term Efficacy and Safety of SHR-1918 in Patients With Suboptimally Controlled Hyperlipidemia
-
11:00-11:20Dynamic Changes of 3D Bending Angle Through the Cardiac Cycle: Implications With Bioresorbable Scaffold PerformanceDynamic Changes of 3D Bending Angle Through the Cardiac Cycle: Implications With Bioresorbable Scaffold Performance
-
11:20-11:40Antispastic Therapy after Coronary Artery Bypass Surgery with Radial Artery Grafts: Four-Year Follow-Up of Randomised ASRAB-Pilot TrialAntispastic Therapy after Coronary Artery Bypass Surgery with Radial Artery Grafts: Four-Year Follow-Up of Randomised ASRAB-Pilot Trial